Emactuzumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Emactuzumab, covering 2018-05-22 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) [Phase 3]